Correction to “Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination” [The Lancet Regional Health – Europe 38 (2024) 100829]

Autor: Hodgson, David, Wilkins, Neil, van Leeuwen, Edwin, Watson, Conall H., Crofts, Jonathan, Flasche, Stefan, Jit, Mark, Atkins, Katherine E.
Zdroj: In The Lancet Regional Health - Europe October 2024 45
Databáze: ScienceDirect